share_log

LDH Growth Corp I (NASDAQ:LDHA) Sees Significant Increase in Short Interest

LDH Growth Corp I (NASDAQ:LDHA) Sees Significant Increase in Short Interest

LDH Growth Corp I(納斯達克股票代碼:LDHA)空頭股數業務大幅增長
Financial News Live ·  2022/11/13 20:03

LDH Growth Corp I (NASDAQ:LDHA – Get Rating) was the recipient of a significant increase in short interest during the month of October. As of October 31st, there was short interest totalling 9,900 shares, an increase of 86.8% from the October 15th total of 5,300 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily volume of 60,300 shares, the short-interest ratio is presently 0.2 days.

LDH Growth Corp I(納斯達克:LDHA-GET評級)是10月份空頭股數大幅增長的接受者。截至10月31日,空頭股數共有9,900股,比10月15日的5,300股增加了86.8%。大約0.0%的股票被賣空。以日均成交量60,300股計算,目前短息比為0.2天。

Institutional Investors Weigh In On LDH Growth Corp I

機構投資者參與LDH Growth Corp I

Hedge funds have recently added to or reduced their stakes in the company. UBS Group AG lifted its stake in LDH Growth Corp I by 167.3% during the third quarter. UBS Group AG now owns 3,301 shares of the company's stock worth $33,000 after purchasing an additional 2,066 shares during the last quarter. DAVENPORT & Co LLC purchased a new position in shares of LDH Growth Corp I in the first quarter worth about $117,000. Context Capital Management LLC purchased a new position in shares of LDH Growth Corp I in the first quarter worth about $230,000. Bank of America Corp DE purchased a new position in shares of LDH Growth Corp I in the first quarter worth about $587,000. Finally, Wealthspring Capital LLC purchased a new position in shares of LDH Growth Corp I in the second quarter worth about $763,000. Institutional investors own 80.23% of the company's stock.

對衝基金最近增持或減持了該公司的股份。瑞銀集團(UBS Group AG)第三季度增持LDH Growth Corp.I的股份增加了167.3%。瑞銀集團(UBS Group AG)在上個季度購買了2,066股瑞銀股票後,目前持有該公司3,301股股票,價值33,000美元。Davenport&Co LLC在第一季度購買了LDH Growth Corp I的新頭寸,價值約11.7萬美元。Context Capital Management LLC在第一季度購買了LDH Growth Corp I的新頭寸,價值約23萬美元。美國銀行DE在第一季購買了LDH Growth Corp I的新頭寸,價值約58.7萬美元。最後,WealthSpring Capital LLC在第二季度購買了LDH Growth Corp I的新頭寸,價值約76.3萬美元。機構投資者持有該公司80.23%的股票。

Get
到達
LDH Growth Corp I
LDH Growth Corp I
alerts:
警報:

LDH Growth Corp I Stock Performance

LDH Growth Corp I股票表現

LDHA stock remained flat at $9.99 during mid-day trading on Friday. The firm has a fifty day moving average of $9.93 and a 200-day moving average of $9.85. LDH Growth Corp I has a 52-week low of $9.62 and a 52-week high of $10.40.

在週五午盤交易中,LDHA股價持平於9.99美元。該公司的50日移動均線切入位在9.93美元,200日移動均線切入位在9.85美元。LDH Growth Corp I觸及52周低點9.62美元和52周高位10.40美元。

About LDH Growth Corp I

關於LDH Growth Corp I

(Get Rating)
(獲取評級)

LDH Growth Corp I does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in a technology-enabled sector. The company was incorporated in 2020 and is based in Miami, Florida.

LDH Growth Corp I沒有重大業務。公司擬與技術行業的一家或多家企業進行合併、股份交換、資產收購、股份購買、重組或類似的業務合併。該公司成立於2020年,總部設在佛羅裏達州邁阿密。

Read More

閲讀更多內容

  • Get a free copy of the StockNews.com research report on LDH Growth Corp I (LDHA)
  • MarketBeat: Week in Review 11/7 – 11/11
  • Oil Is a Compelling Reason The Sell-Off In Stocks Isn't Over
  • Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
  • Six Flags is a Ride You Don't Want to Get Stuck On
  • Hanesbrands May be Signaling a Bad Week for Retail Stocks
  • 免費獲取StockNews.com關於LDH Growth Corp I(LDHA)的研究報告
  • MarketBeat:回顧中的一週11/7-11/11
  • 油價是股市拋售尚未結束的一個令人信服的原因
  • 中盤Neurocrine生物科學是井噴後的第三季度報告嗎?
  • 六面旗幟是一種你不想被困住的旅程
  • Hanesbrand可能發出零售類股本週表現不佳的信號

Receive News & Ratings for LDH Growth Corp I Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LDH Growth Corp I and related companies with MarketBeat.com's FREE daily email newsletter.

獲得LDH Growth Corp I Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對LDH Growth Corp I和相關公司的最新新聞和分析師評級的每日摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論